Unofficial sources say that Hungary's state privatization and holding company, AP Rt, has decided to initiate a tender offer for a 50% stake in drugs and chemical producer Alkaloida Chemicals. A public tender will be held for the stake and a 2 billion forint ($13.7 million) environmental protection investment program will be carried out from the sales revenue, reports MTI Econews.
Provisional figures show that for 1995, Alkaloida recorded an operating profit of 1 billion forint on net sales of 9.1 billion forint. However, the company also had bad debts of 1.36 billion forint. It is forecasting 1996 sales of 8.8 billion forint and operating profit of 1.2 billion forint.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze